KRT4 Antikörper (AA 181-292)
Kurzübersicht für KRT4 Antikörper (AA 181-292) (ABIN7871455)
Target
Alle KRT4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 181-292
-
Verwendungszweck
- Cytokeratin 4 Antibody / KRT4
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A recombinant human partial protein (amino acids 181-292) was used as the immunogen for this Cytokeratin 4 antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the Cytokeratin 4 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the Cytokeratin 4 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- KRT4 (Keratin 4 (KRT4))
-
Andere Bezeichnung
- Cytokeratin 4
-
Hintergrund
- Cytokeratin 4 (KRT4) is an intermediate filament protein associated with Cytokeratin 13 (KRT13). It is expressed in suprabasal cells of non-keratinized stratified squamous epithelium of esophagus, cornea, anus, larynx, pharynx and tongue. Decreased expression of KRT4 is associated with head and neck squamous carcinoma. It is helpful in differentiation of squamous cell carcinoma of esophagus origin from that of thyroid origin.
-
UniProt
- P19013
Target
-